Exo Therapeutics logo

Exo Therapeutics

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.

11-50 employees · est. 2018

VS
Tango Therapeutics logo

Tango Therapeutics

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.

157 employees · est. 2017 · Boston, United States

Tango Therapeutics is the older company (2018 vs 2017); Tango Therapeutics is the larger of the two.

Side-by-Side Comparison

Exo Therapeutics Tango Therapeutics
Founded
2018 2017 older
Headquarters
Not tracked yet Boston, United States
Employees
11-50 157 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Post Ipo Equity
Total Funding
$103.00M $351.00M
Funding Rounds
2 4
Services
Not tracked yet Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations
Target Customers
Not tracked yet Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors
Taxonomy
Precision Therapeutics, Drug Discovery, Small Molecules, ExoSight Platform, Exosites, Enzyme Activity, Oncology, Inflammation, Pharmaceutical Targets, Therapeutic Outcomes, World-class Research, Pioneering Technology, Breakthrough Treatments, Deep Pipeline, Data-driven Research Clinical-stage, Precision Medicine, Cancer Treatment, Tumor Suppressor Targeting, Synthetic Lethality, CRISPR-based Discovery, DNA Sequencing, Immuno-oncology, Oncogenic Drivers, Immune Evasion, Functional Genomics, Drug Discovery, Targeted Therapies, Novel Drug Targets
Website
exo-therapeutics.com tangotx.com
Exo Therapeutics logo

About Exo Therapeutics

Exo Therapeutics, founded in 2018, is a promising biotechnology and pharmaceutical startup that is making waves in the industry with its innovative approach to drug discovery and development. The company's slogan, "Advancing precision therapeutics for challenging pharmaceutical targets through pione...

Tango Therapeutics logo

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...

We will tell you when either one moves

BounceWatch watches Exo Therapeutics and Tango Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Exo Therapeutics and Tango Therapeutics — by email.

Frequently Asked Questions

Exo Therapeutics — Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.. Tango Therapeutics — Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Exo Therapeutics has raised $103.00M while Tango Therapeutics has raised $351.00M.
Exo Therapeutics and Tango Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Exo Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Exo Therapeutics on 26 Jul 2024, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy